Will Heart Failure Be the Next Growth Market in Transcatheter Structural Heart?
Contact Us
Visit Our Desktop Site For More Resources
News & Resources
news
news
2019
July
2017
CorAssist Cardiovascular Announces First Patient Treated with the CORolla® TAA Implant in a Stand-Alone procedure at RAMBAM Health Care Campus.
2017
CorAssist Cardiovascular announces initiation of the CORolla® TAA first-in-human stand-alone clinical study at RAMBAM Health Care Campus.
March
2013
CorAssist Cardiovascular announces enrollment of first patient treated with the CORolla® TAA implant as an add-on to surgical valve replacement.
October
2010
CorAssist Cardiovascular presents results of the first-generation implant- ImCardia®.
With 24 months follow up of safety in humans The ImCardia Has demonstrated trends of efficacy bringing the 2nd Gen – The CORolla® one step closer to the clinic evaluation.
presentations & abstracts
Relaxing The Diastolic Heart, Innovative Solution For The Treatment Of Heart Failure With Preserved Ejection Fraction (HFpEF)
Presented At ICI 2020 By Y. Feld
Energy Transfer From Systole To Diastole, A Novel Device For Heart Failure With Preserved Ejection Fraction
Presented At PCR 2019 By Y. Feld
Innovative Solutions For Heart Failure With Preserved Ejection Fraction (HFpEF)
Presented At ICI 2018 By Y. Feld
publications
General
2020
Diagnosis And Treatment Of Heart Failure With Preserved Left Ventricular Ejection Fraction
Robert J Henning, World J Cardiol. 2020, 26; 12(1): 7-25.
2019
Heart Diseases And Stroke Statistics
Emelia J. Benjamin Et Al., Circulation. 2019; 139: E56-E528.
2017
ACC/AHA/HFSA Focused Update Of The 2013 ACCF/AHA
Guideline For The Management Of Heart Failure
Clyde W. Yancy Et Al. Circulation. 2017; 136: E1¬37–E161.
About Us
2021
The CORolla device for energy transfer from systole to diastole: a novel treatment for heart failure with preserved ejection fraction
Yair Feld, Yotam Reisner, Gideon Meyer-Brodnitz and Ruti Hoefler. Hear Failure Reviews. 2021.
2019
Novel percutaneous interventional therapies in heart failure with preserved ejection fraction: an integrative review
Alexanderu Burlacu, Paul Simion, Ionut Nistor, Adrian Covic and Grigore Tinica. Heart Failure Reviews. 2019; 24(5): 793-803.
2015
Advances in the pathophysiology and treatment of heart failure with preserved ejection fraction
Sara Tannenbaum and Gabriel T. Sayer. Curr Opin Cardiol. 2015; 30(3): 250-258
2011
Energy transfer from systole to diastole: A novel device-based approach for the treatment of diastolic heart failure
Yair Feld, Shay Dubi, Yotam Reisner, Ehud Schwammenthal, Rona Shofti, Alon Pinhasi, Shemy Carasso, Amir Elami, Acute Cardiac Care. 2011; 13: 232-242.
2006
Future strategies for the treatment of diastolic heart failure
Yair Feld, Shay Dubi, Yotam Reisner, Ehud Schwammenthal and Amir Elami, Acute Cardiac Care. 2006; 8: 13-20.
resources
American Heart Association
The American Heart Association is a national voluntary health agency whose mission is: “Building healthier lives, free of cardiovascular diseases and stroke.”
Heart Failure Society Of America
The Heart Failure Society Of America, Inc. (HFSA) Represents The First Organized
Effort By Heart Failure Experts From The Americas To Provide A Forum For All Those Interested In Heart Function, Heart Failure, And Congestive Heart Failure (CHF) Research And Patient Care.
European Society Of Cardiology
Mission: to reduce the burden of Cardiovascular Disease in Europe.
Guidelines physicians use for the treatment and management of patients with acute and chronic heart failure. The guidelines assist the physician in decision making as well as provide a standard of care. These guidelines are written by a team of experts in the field and are periodically updated.
A through explanation on heart failure with preserved ejection fraction, depicting causes for the disease, treatment and management.
Contact Us
CorAssist Cardiovascular Ltd.
57 Derech Ha’atzmaut,
PO Box 33066,
Haifa 3303329, Israel